Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact


Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo in 1993 as a first generation internet teaching tool consolidating human embryology teaching for first year medical students.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human.

The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.


WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

December 20, 2012--------News Archive Return to: News Alerts


Neatly organized axons travel up and down the spinal cord (left) of a healthy, embryonic mouse. Axons in mice without dystroglycan (right) are tangled and disorganized.

Photo by Kevin Wright







WHO Child Growth Charts

       

Dystroglycan Protein Creates Paths For Growing Nerve Cells

Links have been made between muscular dystrophy, defective nerve wiring and defective axon wiring in the spinal cord

Working with mice, Johns Hopkins scientists have discovered that a particular protein helps nerve cells extend themselves along the spinal cord during mammalian development.

Their results shed light on the subset of muscular dystrophies that result from mutations in the gene that holds the code for the protein, called dystroglycan, and also show how the nerve and muscle failings of the degenerative diseases are related.


As mammals like mice and humans develop,
nerve cells in the brain and spinal cord must form
connections with themselves and with muscles
to assure proper control of movement.

Nerve cells sometimes extend the whole length
of the spinal cord to connect sensory nerves bearing information, for example, from the legs to the brain.

To do so, nerve cells anchor their “headquarters,”
or cell bodies, in one location, and then extend a long,
thin projection all the way to their target locations.

These projections, or axons, can be
10,000 times longer than the cell body.


In their report published in the journal Neuron on Dec. 6, the authors suggest that, during fetal development, axons extend themselves along specific pathways created by dystroglycan.

“Dystroglycan creates a path and then binds other molecules that act as traffic signs, providing directional cues for axons en route to their targets,” says David Ginty, Ph.D., a Howard Hughes investigator and professor of neuroscience in the Institute for Basic Biomedical Sciences at the Johns Hopkins University School of Medicine.

To find new genes associated with axon migration, Kevin Wright, Ph.D., a postdoctoral fellow in Ginty’s laboratory, chemically provoked random genetic changes throughout the genomes of mice and then examined their axons for defective organization.


What stood out were mutations in two genes
that resulted in axon growth patterns similar
to those in mice lacking the protein Slit,
which is known to provide directional
cues for nerve axons.


Digging deeper, Wright found the genes that
encode for the proteins B3gnt1and ISPD,
both of which had recently been implicated
in adding sugar molecules to dystroglycan.

Sugars bound to proteins often control protein activity,
so B3gnt1 and ISPD led the team to focus on
dystroglycan as the key to the axon flaws they saw.


Through a series of genetic and biochemical experiments, the scientists learned that B3gnt1 and ISPD are indeed required for dystroglycan to work properly.

Dystroglycan is made and released by specific cells within the spinal cord. It acts as a hub for tethering instructional molecules, like Slit, that guide nerve axons as they grow. But before dystroglycan can bind the instructional molecules, B3gnt1 and ISPD must attach sugars to it.

As expected, mice with defective dystroglycan usually have symptoms similar to mice with defective B3gnt1, ISPD or Slit. Moreover, the development of their muscles and nerves is severely disturbed, and the animals die soon after birth. Mouse fetuses completely missing any of the four proteins usually die before they are born.

Without dystroglycan or its helpers, the axons don’t know where to go and the connection between nerve cells is lost, Ginty says.


“Dystroglycan creates the road,
B3gnt1 and ISPD add tar on top,
and directional molecules like
Slit stick to
the tar and point the axons in the right direction.

If any part of the collaboration is missing, the axons
overshoot their targets or don’t turn where they should.

Many muscular dystrophies are caused by
a defect specific to muscles. Children with
defects in dystroglycan suffer from muscle
weakening and bad nerve connections.

Now we have mice with similar
symptoms that we can study further.”

David Ginty, Ph.D.
Howard Hughes investigator, professor of neuroscience
Institute for Basic Biomedical Sciences
Johns Hopkins University School of Medicine


Other authors of the report include Krissy Lyon and Daniel Leahy of the Johns Hopkins University School of Medicine and Haiwen Leung and Le Ma of the University of Southern California.

This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS34814, NS062047), the National Institute of Child Health and Human Development (R01HD055545), the Johns Hopkins Brain Science Institute and the Howard Hughes Medical Institute.

Original article: http://www.hopkinsmedicine.org/news/media/releases/
protein_creates_paths_for_growing_nerve_cells